• 383
    0

    The Food and Drug Administration has approved the drug Krintafel (tafenoquine) for the treatment of malaria following a Priority Review this past Friday. The drug, developed by GSK Pharmaceuticals and Medicines for Malaria Venture, is a single dose medication designed for people who’ve had malaria before. It prevents the relapse of malaria caused by Plasmodium ...
  • 507
    0

    With the parasite responsible for most malaria cases, Plasmodium falciparum, developing resistance to widely-used treatments, researchers have developed a new drug to fight the mosquito-born disease. Results of a clinical trial published in the journal Lancet Infectious Diseases have shown the drug to be effective against non-severe cases of malaria. The drug, called AQ-13, was ...